NCT01107015

Brief Summary

The Mobile Diabetes Intervention Study trial is evaluating a diabetes coaching system, using mobile phones and patient/ physician internet portals to allow patient-specific treatment and communication by their primary care physician. We hypothesize that timely information provided to patients and their physicians can result in reduction of A1c over 1 year.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
213

participants targeted

Target at P50-P75 for not_applicable diabetes

Timeline
Completed

Started Jun 2008

Typical duration for not_applicable diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

April 17, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 20, 2010

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2010

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
6.5 years until next milestone

Results Posted

Study results publicly available

March 1, 2018

Completed
Last Updated

May 31, 2023

Status Verified

December 1, 2019

Enrollment Period

2.2 years

First QC Date

April 17, 2010

Results QC Date

September 29, 2017

Last Update Submit

May 4, 2023

Conditions

Keywords

DiabetesGlucose controlDiabetes monitoringCare managementElectronic communicationMobile phone technologySelf care

Outcome Measures

Primary Outcomes (1)

  • HBA1c at One Year

    one year

Study Arms (4)

Group 1: Usual Care

NO INTERVENTION

Provider-driven care, based in office, no special diabetes management; Patient self-monitoring of blood glucose (SMBG)

Group 2: patient intervention

ACTIVE COMPARATOR

Home diabetes monitoring by patient using mobile phone to communicate information and receive feedback

Device: Tailored Patient Intervention

Group 3: patient-physician intervention

ACTIVE COMPARATOR

Home diabetes monitoring by patient using mobile phone to communicate and receive feedback; Physician can access unanalyzed information from the patient's electronic logbook

Device: Patient-physician intervention

Group 4: data analyzed intervention

ACTIVE COMPARATOR

Home diabetes monitoring by patient using mobile phone to communicate information and receive feedback; Physician can access raw and analyzed patient data; Physician receives report summary and treatment recommendations

Device: Patient and PCP intervention with analyzed data

Interventions

Patients select one of two mobile phone models, receive a one-year unlimited mobile phone data and phone service plan, receive the study treatment phone software and have access to the web-based individual patient portal. Given system-driven guidance on when to test blood glucose (bg) based on disease status, medication regimen, and time of poorest control. Patients enter bg data, carbohydrates consumed, diabetes medications taken and miscellaneous comments regarding diabetes self-care. Messages are sent to the patient's mobile phone giving feedback on entered data. Entered data are captured in real-time in the web-based logbook. Patients may provide their PCPs with printed copies of their logbooks and other information but physicians do not have access to the patient portal system. Patient action plans summarizing the patient-entered data and identifying possible self-management actions for improving their diabetes control are electronically sent to the patients every 2.5 months.

Group 2: patient intervention

Patients select one of two mobile phone models, receive a one-year unlimited mobile phone data and phone service plan, receive the study treatment phone software and have access to the web-based individual patient portal. Given system-driven guidance on when to test blood glucose (bg) based on disease status, medication regimen, and time of poorest control. Patients enter bg data, carbohydrates consumed, diabetes medications taken and miscellaneous comments regarding diabetes self-care. Messages are sent to the patient's mobile phone giving feedback on entered data. Entered data are captured in real-time in the web-based logbook. PCPs are provided access to a web portal where they may choose to review their patients' electronic logbooks. This is "raw" patient data that have not been analyzed.

Group 3: patient-physician intervention

Patients select one of two mobile phone models, receive a one-year unlimited mobile phone data and phone service plan, receive the study treatment phone software and have access to the web-based individual patient portal. Given system-driven guidance on when to test blood glucose (bg) based on disease status, medication regimen, and time of poorest control. Patients enter bg data, carbohydrates consumed, diabetes medications taken and miscellaneous comments regarding diabetes self-care. Messages are sent to the patient's mobile phone giving feedback on entered data. Entered data are captured in real-time in the web-based logbook. PCPs are provided access to a secure web portal where they can see their patients' electronic logbooks. PCPs are provided with data analysis reports. The PCP is reminded that all data analysis is based on patient-entered, unvalidated data. The PCP has the option to use this information and remains responsible for all treatment decisions.

Group 4: data analyzed intervention

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Type 2 diabetic \[patient\]
  • A1c equal to or greater than 7.5 \[patient\]
  • years of age at time of recruitment \[patient\]
  • Access to the internet (does not need to be at their home, elsewhere is fine e.g. work) \[patient\]
  • E-mail account \[patient\]
  • Must speak English \[patient\]

You may not qualify if:

  • No insulin pump \[patient\]
  • No current alcohol or drug abuse- must be sober 1 year \[patient\]
  • Not currently pregnant \[patient\]
  • No terminal diagnosis \[patient\]
  • No dementia or Alzheimer's \[patient\]
  • No active chemotherapy \[patient\]
  • No significant hearing impairment \[patient\]
  • Poorly corrected vision that would impede use of phone \[patient\]
  • No mute or aphasia \[patient\]
  • No diagnosis of schizophrenia, bipolar disorder, or major psychosis \[patient\]
  • No Medicaid or Medicare
  • No uninsured

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Maryland, Baltimore

Baltimore, Maryland, 21201, United States

Location

Related Publications (4)

  • Quinn CC, Gruber-Baldini AL, Shardell M, Weed K, Clough SS, Peeples M, Terrin M, Bronich-Hall L, Barr E, Lender D. Mobile diabetes intervention study: testing a personalized treatment/behavioral communication intervention for blood glucose control. Contemp Clin Trials. 2009 Jul;30(4):334-46. doi: 10.1016/j.cct.2009.02.004. Epub 2009 Feb 27.

    PMID: 19250979BACKGROUND
  • Quinn CC, Swasey KK, Torain JM, Shardell MD, Terrin ML, Barr EA, Gruber-Baldini AL. An mHealth Diabetes Intervention for Glucose Control: Health Care Utilization Analysis. JMIR Mhealth Uhealth. 2018 Oct 15;6(10):e10776. doi: 10.2196/10776.

  • Quinn CC, Butler EC, Swasey KK, Shardell MD, Terrin MD, Barr EA, Gruber-Baldini AL. Mobile Diabetes Intervention Study of Patient Engagement and Impact on Blood Glucose: Mixed Methods Analysis. JMIR Mhealth Uhealth. 2018 Feb 2;6(2):e31. doi: 10.2196/mhealth.9265.

  • Quinn CC, Swasey KK, Crabbe JCF, Shardell MD, Terrin ML, Barr EA, Gruber-Baldini AL. The Impact of a Mobile Diabetes Health Intervention on Diabetes Distress and Depression Among Adults: Secondary Analysis of a Cluster Randomized Controlled Trial. JMIR Mhealth Uhealth. 2017 Dec 7;5(12):e183. doi: 10.2196/mhealth.8910.

Related Links

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Results Point of Contact

Title
Cindy Geppi
Organization
University of Maryland, Baltimore

Study Officials

  • Geppi

    University of Maryland, Baltimore

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2010

First Posted

April 20, 2010

Study Start

June 1, 2008

Primary Completion

August 1, 2010

Study Completion

September 1, 2011

Last Updated

May 31, 2023

Results First Posted

March 1, 2018

Record last verified: 2019-12

Locations